Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +16.67%
#4 Fabric Protocol Fabric Protocol +16.56%
#5 Bedrock Bedrock +8.62%
#6 Cap Cap +8.41%
#7 Perle Perle +5.94%
#8 stake.link stake.link +4.91%
#9 DUSK Network DUSK Network +3.59%
#10 Figure Heloc Figure Heloc +3.49%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Visioneering Technologies, Inc. Visioneering Technologies, Inc.

Visioneering Technologies, Inc.

VTI
주식 순위 #38209
Visioneering Technologies, Inc. is a medical device company focused on the... Visioneering Technologies, Inc. is a medical device company focused on the development, production, marketing, and distribution of contact lenses. Its commercial activities extend across North America, Europe, and the Asia-Pacific regions. The company's primary offering is NaturalVue, a multifocal contact lens engineered to help adults experiencing presbyopia and children with myopia. Visioneering Technologies was established in 2008 and has its main office situated in Alpharetta, Georgia.
주가
$0.04200239
마지막 동기화: 2025-02-17
시가총액
$1.13M
변동 (1일)
0.21%
변동 (1년)
0.00%
국가
US
거래 Visioneering Technologies, Inc. (VTI)

카테고리

Healthcare
Visioneering Technologies, Inc. (VTI)의 P/S 비율
August 2026 기준 P/S 비율 TTM: 0.30
Visioneering Technologies, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0.30입니다. 2022년 말 기준 P/S 비율은 0.99였습니다.
Visioneering Technologies, Inc.의 P/S 비율 기록 (2016 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 0.30 -56.49%
2023 0.69 -31.08%
2022 0.99 -62.32%
2021 2.64 -31.09%
2020 3.83 24.70%
2019 3.07 -66.79%
2018 9.25 -88.69%
2017 81.77 -99.69%
2016 26.49K 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
3.95 1,216.49%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.83 1,509.79%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 827.68%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.31 1,001.97%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
7.61 2,435.01%
US